Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.150
+0.140 (4.65%)
Jan 17, 2025, 4:00 PM EST - Market closed

Neuphoria Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
11.07B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024---
Jun 30, 2023---
Jun 30, 20226.06M5.13M552.46%
Jun 30, 2021928.07K-2.06M-68.98%
Jun 30, 20202.99M-4.37M-59.37%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amazon.com 620.13B
Apple 391.04B
Berkshire Hathaway 369.89B
Berkshire Hathaway 369.89B
Alphabet 339.86B
Alphabet 339.86B
Microsoft 254.19B
Meta Platforms 156.23B
Revenue Rankings